silica/inflammation

FIELD The present invention relates to a depot for drug delivery. In particular the present invention relates to a depot suitable for sustained-release drug delivery. Further the present invention relates to use of a depot in the preparation of a parenteral sustained-release medicament. In

FIELD OF THE INVENTION The present invention relates to a formulation for the delivery of an anti-inflammatory agent to a subject. In a particular application of the invention, the formulation comprises oil-based or aqueous droplets comprising indomethacin

FIELD OF THE INVENTION The invention concerns new substances based upon fine pyrogenic silica, or AEROSIL (commercial pharmaceutical names SILARD P, SILEX, ATOXIL) that contains serrathiopeptidase immobilized thereon. Such composition is active in the lysis of necrotizing tissues, cleanses wound

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH This invention was made with government support under Grant No. P50 AT00474 awarded by the National Institute of Health. The United States Government has certain rights in this invention. TECHNICAL FIELD The present invention is relevant to the field

CROSS-REFERENCE TO RELATED APPLICATIONS None. STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT None. REFERENCE TO SEQUENCE LISTING None. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the isolation, purification and structural identification

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the isolation, purification and structural identification of the bioactive component of water extracts of Cat's Claw (Uncaria species). The bioactive component is identified as quinic acid lactone. The present

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the isolation, purification and structural identification of the bioactive component of water extracts of Cat's Claw (Uncaria species). The bioactive component previously was identified in vitro as quinic acid

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to the isolation, purification and structural identification of the bioactive component of water extracts of Cat's Claw (Uncaria species). The bioactive component previously was identified in vitro as quinic acid

FIELD OF THE INVENTION The present invention is generally in the field of delivery of the combination of IL-2 and TGF-.beta., using nanoparticulates, which may be targeted to CD4 expressed by a desired cell or tissue type to enhance efficacy BACKGROUND OF THE INVENTION CD4+ T cells represent an

FIELD OF THE INVENTION The present invention is generally in the field of delivery of the combination of IL-2 and TGF-.beta., using nanoparticulates, which may be targeted to CD4 expressed by a desired cell or tissue type to enhance efficacy. BACKGROUND OF THE INVENTION CD4+ T cells represent an

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to the chemistry of biologically active compounds. More particularly to specifically substituted porphyrin and chlorin derivatives that can be used as photosensitizers for a wide range of light irradiation treatments such as

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to the chemistry of biologically active compounds. More particularly to specifically substituted porphyrin and chlorin derivatives that can be used as photosensitizers for a wide range of light irradiation treatments such as

TECHNICAL FIELD The invention relates to oral hygiene, including cleaning of the teeth and gums, and supplemental addition of trace elements and calcium to the teeth and gums. BACKGROUND Tooth powder as used in daily life, has a long history. With the continuous development of science and

FIELD OF THE INVENTION This invention belongs to pharmaceutical preparations suitable for preparing solutions for injectable preparations of antimicrobial pharmaceuticals, and to technologies for compounding thereof; it may be used in medicine and veterinary medicine when treating contagious and

BACKGROUND OF THE INVENTION The present invention relates to an ophthalmic prosthetic device and more particularly to an anti-reactive coated intraocular lens. As is well known in the field of ophthalmology, an intraocular lens, when surgically implanted, is designed to replace a previously or